Research workbench
Crystal structure of human B7-H4 igv-like domain
Analyse Crystal structure of human B7-H4 igv-like domain in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 4GOS
- Type
- protein
- Length
- 115 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- V-set domain-containing T-cell activation inhibitor 1
- UniProt
- Q7Z7D3
- Ligands
- NAG, MAN, BMA
Structure
x-ray diffraction · 1 distinct chain · 10% helix, 50% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | V-set domain-containing T-cell activation inhibitor 1 | protein | 115 | 10% helix, 50% strand | Q7Z7D3 |
Ligands and binding sites
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A
- MAN · alpha-D-mannopyranose · sugar · 2 copies · chains A
- BMA · beta-D-mannopyranose · sugar · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Modifications
Observed in the structure: 1 disulfide, 1 glycan (disulfide, N-glycosylation).
Compared structures
- 4GOS · Crystal structure of human B7-H4 IgV-like domain · the same entry in another collection · chain A against A, TM-score 1.00
- Q7Z7D3 · AlphaFold monomer V2.0 prediction for V-set domain-containing T-cell activation inhibitor… · a predicted model of the same protein · chain A against A, TM-score 0.98
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q7Z7D3
- Elsewhere: RCSB PDB 4GOS · PDBe 4GOS · UniProt Q7Z7D3
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.